A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
NCT06467383 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2025-01-14
Summary
This is a non-interventional, retrospective observational study to improve knowledge regarding the diagnosis and treatments of patients who have/had non-small cell lung cancer (NSCLC), either early stage (stage I-II).
Conditions
- Non-small Cell Lung Cancer
- NSCLC
- NSCLC, Stage III
- NSCLC, Stage I
Sponsors & Collaborators
-
YGHEA, CRO Division of Ecol Studio spa
collaborator INDUSTRY -
MSD Italia S.r.l.
lead INDUSTRY
Principal Investigators
-
Giada Iuliano, MD · MSD Italia srl
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-25
- Primary Completion
- 2025-06-24
- Completion
- 2025-06-24
Countries
- Italy
Study Locations
More Related Trials
-
Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLC
NCT06808113 ·Status: ACTIVE_NOT_RECRUITING
-
Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China
NCT02458651 ·Status: COMPLETED
-
Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients
NCT05673798 ·Status: COMPLETED
-
EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients
NCT07096258 ·Status: RECRUITING
-
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NCT07325864 ·Status: RECRUITING
-
Prospective Observational Study on ES-SCLC
NCT07173946 ·Status: NOT_YET_RECRUITING
-
Comprehensive Demographics and Clinical Profile of NSCLC Patients
NCT06725537 ·Status: NOT_YET_RECRUITING
-
A2R and Ectonucleotidases Expression in Lung Cancer Circulating Tumor Cells
NCT05648188 ·Status: WITHDRAWN
-
Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma
NCT03156868 ·Status: COMPLETED
-
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer
NCT05979623 ·Status: COMPLETED
-
Prognostic Value of PD-L1 in NSCLC
NCT03078959 ·Status: UNKNOWN
-
Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
NCT06833632 ·Status: RECRUITING
-
Lung Cancer Registry for Lung Cancer Patients
NCT03276429 ·Status: COMPLETED
-
Distribution and Prognostic Impact of Oncogenic Drivers in Metastatic Lung Adenocarcinoma : a Retrospective Monocentric Study in Nancy University Hospital Center
NCT04493827 ·Status: COMPLETED
-
Non-small Cell Lung Cancer and Quality of Life
NCT00818402 ·Status: COMPLETED
-
Tumor Cell Plasticity and Aggressiveness in Human Non-small Cell Lung Cancer
NCT06409416 ·Status: NOT_YET_RECRUITING
-
Factors Determining the Prognosis in NSCLC Stage IV
NCT04306094 ·Status: UNKNOWN
-
A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China
NCT07316062 ·Status: RECRUITING
-
Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients
NCT05619562 ·Status: COMPLETED
-
Radiomics and Radiogenomics of Non-small Cell Lung Cancer
NCT06331975 ·Status: COMPLETED ·Phase: NA
-
Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:
NCT04836975 ·Status: COMPLETED
-
A Chart Review Study of Adults With Advanced NSCLC
NCT05207423 ·Status: COMPLETED
-
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients
NCT07188480 ·Status: RECRUITING ·Phase: NA
-
Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil
NCT04947683 ·Status: COMPLETED
-
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
NCT02035683 ·Status: UNKNOWN ·Phase: NA